関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 7-Bromo-1-benzofuran | HCID 113628 | — |
| 反応物 | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| 試薬 | Sodium t-butoxide | HCID 23676156 | — |
| 触媒 | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| 触媒 | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| 溶媒 | Toluene | HCID 1140 | — |
| 生成物 | Tert-butyl 4-(7-benzo[b]furanyl)piperazine-1-carboxylate | HCID 23300012 | 84.06% |
反応手順
7-bromobenzofuran (2 g, 10.15 mmol), tert-Butyl 1-piperazinecarboxylate (1.891 g, 10.15 mmol), Tris(dibenzylideneacetone)dipalladium(0) (0.465 g, 0.51 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (0.484 g, 1.02 mmol) and sodium t-butoxide (1.856 mL, 21.32 mmol) were heated to 100 °C in toluene (10 mL) for 3h. The mixture was allowed to cool to ambient temperature. Ethylacetate was added and the mixture was filtered through Celite. The filtrate was concentrated and redissolved in ethylacetate. The organic mixture was washed with satd. aqueous Na2CO3 and brine. The organic phase was separated, dried over Na2CO3, filtered and the solvent removed by rotary evaporation. The crude product was redissolved in diethylether and loaded onto a silica gel column and eluted with 0-50% EtOAc in heptanes. The collected fractions were combined and the solvent removed by rotary evaporation to yield tert-butyl 4-(benzofuran-7-yl)piperazine-1-carboxylate (2.58 g, 84 %). MS (m+1) = 303. HPLC Peak RT = 5.97 minutes is product. Purity = 94%.
情報源と証拠
| 出典データセット | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-decd3260950345c1bc7b269e3329c8ac |
|---|
| 出典メモ | 750 AstraZeneca ELN dataset |
|---|